Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07205107) titled 'Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris' on Sept. 24.
Study Type: Observational
Primary Sponsor: Bausch Health Americas, Inc.
Condition:
Acne Vulgaris
Intervention:
Drug: clindamycin phosphate, adapalene and benzoyl peroxide
Recruitment Status: Recruiting
Date of First Enrollment: October 2025
Target Sample Size: 200
Countries of Recruitment:
Canada
To know more, visit https://clinicaltrials.gov/study/NCT07205107
Published by HT Digital Content Services with permission from Health Daily Digest....